BAFNAPH
NSEBafna Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹204.61
4.01 (2.00%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹484 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
48.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹78.18+161.7%
52W High₹227-9.9%
Current Price
₹204.61
Circuit Limits (2%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹200.52
Upper Circuit₹208.70
Reference Price
₹204.61
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹217.12
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
Composite score 43.14 (BUY) with 84.8% confidence
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
85%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
192.99
EMA50
169.96
EMA200
142.02
Price Action
MIXED
NEUTRAL
Higher Highs4
Higher Lows3
Lower Highs5
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹213.36
₹227.00
Support (Below)
₹202.06
₹176.33
₹173.26
₹147.95
₹143.46
Volume Analysis
TrendDECREASING
Change-44.40%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Recent Price Gaps
Gap Down
3 days ago • 1.75%
BEARISH
Gap Down
4 days ago • 2.00%
BEARISH
Gap Down
5 days ago • 1.57%
BEARISH
Stop Loss Levels
Fixed Risk
1% Risk₹202.56
3% Risk₹198.47
5% Risk₹194.38
7% Risk (Custom)
₹190.29Technical Levels
1x ATR (Volatility)₹196.79
2x ATR (Swing)₹188.97
3x ATR (Trend)₹181.15
Immediate Support₹202.06
Moving Averages
EMA 9 (Short-term)₹204.35
EMA 20 (Medium-term)₹192.99
EMA 50 (Trend)₹169.96
EMA 200 (Long-term)₹142.02
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹33.2 Cr | ₹39.1 Cr | ₹34.6 Cr | ₹35.5 Cr |
| Net Profit | ₹94,77,000 | ₹1.3 Cr | ₹3.4 Cr | ₹3.1 Cr |
| EPS | ₹0.40 | — | ₹1.43 | ₹1.32 |
| Operating Profit | ₹3.2 Cr | ₹2.2 Cr | ₹5.7 Cr | ₹5.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Bafna Pharmaceuticals Limited | ₹204.61 | +2.00% | 48.0 | ₹484 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 17 Sept 2024 | Annual General Meeting | AGM |
| 20 Jul 2022 | Annual General Meeting | AGM |
| 05 Aug 2021 | Annual General Meeting | AGM |
| 23 Jul 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BAFNAPH
View AllNEWS
negative
Business Standard - Markets 31d ago
GRM Overseas Ltd leads losers in 'B' group
Bafna Pharmaceuticals Ltd, Agri-Tech (India) Ltd, Master Trust Ltd and Alacrity Securities Ltd are among the other losers in the BSE's 'B' group today, 09 June 2026.
AGRITECHBAFNAPHBSEGRMOVERMASTERMASTERTRTECHTRUSTZTECHCapital GoodsFast Moving Consumer Goods